All News #Library
Rare Diseases
After Alfasigma licensing deal, Lynavoy picks up FDA nod
19 Mar 2026 //
FIERCE PHARMA
Alfasigma Acquires Exclusive Rights To Parenteral Adibelivir
13 Jan 2026 //
PHARMIWEB
Intercept Withdraws Ocaliva for PBC from US Market, Trial on Hold
11 Sep 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support